SCHEMBL6496689

SCHEMBL6496689

COC[CH]c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.46
PTGS2 P35354 1/20 0.39
CYP1A2 P05177 2/20 0.38
MAOB P27338 3/20 0.37
AHR P35869 2/20 0.37
LMNA P02545 1/20 0.36
CYP2A6 P11509 1/20 0.36
AKR1C3 P42330 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOA P21397 1/20 0.35
NFE2L2 Q16236 1/20 0.35
TACR2 P21452 1/20 0.35
TRPA1 O75762 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10812999 0.79 CYP2A6 (0.48) PTGS2CYP2A6ALDH1A1MAPTHPGD
SCHEMBL10888784 0.78 HSD17B10 (0.43) HSD17B10PTGS2CYP1A2MAOBAHR
SCHEMBL10487688 0.78 HSD17B10 (0.43) HSD17B10MAOBAHRLMNACYP2A6
SCHEMBL12016063 0.78 NFE2L2 (0.44) PTGS2CYP1A2MAOBAHRMAOA
SCHEMBL8988570 0.77 ALDH5A1 (0.46) HSD17B10PTGS2CYP1A2MAOBLMNA
SCHEMBL16958674 0.77 AHR (0.42) CYP1A2AHRMAPTL3MBTL1
SCHEMBL16961107 0.77 TRPA1 (0.43) ALDH1A1MAPTTRPA1
SCHEMBL2580643 0.76 AKT1 (0.42) CYP1A2MAOBLMNACYP2A6ALDH1A1
SCHEMBL1609713 0.75 HSD17B10 (0.55) HSD17B10PTGS2CYP1A2MAOBAHR
SCHEMBL10887511 0.75 CYP1A2 (0.48) HSD17B10PTGS2CYP1A2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844347-B1 Cyclic guanosine monophosphate modulators; cardiovascular diseases; guanylate cyclase activation AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-01-18 US disclosed